Saturday, September 29, 2018

FDA approves a new antibacterial drug to treat a serious lung disease using a novel pathway to spur innovation

  1. FDA approves a new antibacterial drug to treat a serious lung disease using a novel pathway to spur innovation  FDA.gov
  2. FDA Approves Inhaled Amikacin for Non-TB Lung Infection  MedPage Today
  3. Insmed's treatment-resistant lung disease drug gets FDA approval  ReutersFull coverage
(CLICK HERE TO READ AND SEE MORE

0 comments:

Post a Comment